Valuation: IRADIMED CORPORATION

Market Cap 1.28B 1.12B 1.04B 959M 1.82B 123B 1.85B 12.47B 4.85B 60.04B 4.81B 4.71B 208B P/E 2026 *
52.5x
P/E 2027 * 46.3x
Enterprise Value 1.28B 1.12B 1.04B 959M 1.82B 123B 1.85B 12.47B 4.85B 60.04B 4.81B 4.71B 208B EV / Sales 2026 *
14.1x
EV / Sales 2027 * 12.7x
Free-Float
64.8%
Yield 2026 *
-
Yield 2027 * -
1 day-4.70%
1 week-1.43%
Current month+1.12%
1 month+2.38%
3 months-0.71%
6 months-3.36%
Current year-0.66%
1 week 96.43
Extreme 96.43
102.99
1 month 89.69
Extreme 89.69
102.99
Current year 76.95
Extreme 76.95
107.9
1 year 55.11
Extreme 55.1093
107.9
3 years 36.12
Extreme 36.12
107.9
5 years 26
Extreme 26
107.9
10 years 7.85
Extreme 7.85
107.9
Manager TitleAgeSince
Chief Executive Officer 72 27/05/2020
Director of Finance/CFO 64 19/06/2022
Chief Tech/Sci/R&D Officer - 31/12/2019
Director TitleAgeSince
Chairman 72 15/06/2020
Director/Board Member 70 31/12/2018
Director/Board Member 73 31/12/2013
Date Insider Type Main position Quantity % Market Cap.
06-19Fiscal year

Chief Financial Officer

13,911 0.1088%
06-03Sell

Director

-3,000 0.0235%
05-31Sell

Chief Executive Officer

-2,500 0.0196%
Change 5-day change 1-year change 3-year change Capi.($)
-4.70%-1.43%+62.90%+103.57% 1.28B
+1.13%+3.69%-19.07%-27.15% 12.53B
+2.44%-6.05%+85.51%+14.55% 4.95B
-0.70%+0.60%-35.04%-63.94% 1.18B
+0.58%+2.15%-39.86%-48.19% 1.07B
-1.15%+0.51%-48.14% - 881M
-0.06%-5.82%+158.23%+143.31% 618M
+7.50%-17.10%+32.54% - 283M
-0.35%-11.37%-53.93%+208.58% 254M
-0.97%-2.62%-27.61%-43.59% 138M
Average +0.37%-5.08%+11.55%+35.89% 2.32B
Weighted average by Cap. +0.90%-0.86%+9.84%-5.77%

Financials

2026 *2027 *
Net sales 91.2M 79.99M 73.85M 68.24M 129M 8.73B 132M 888M 345M 4.27B 342M 335M 14.83B 101M 88.5M 81.7M 75.5M 143M 9.66B 146M 982M 382M 4.73B 379M 371M 16.41B
Net income 24.55M 21.53M 19.88M 18.37M 34.82M 2.35B 35.52M 239M 92.86M 1.15B 92.19M 90.17M 3.99B 27.8M 24.38M 22.51M 20.8M 39.43M 2.66B 40.22M 271M 105M 1.3B 104M 102M 4.52B
Net Debt - -
Logo IRADIMED CORPORATION
IRadimed Corporation develops, manufactures, markets and distributes magnetic resonance imaging (MRI) compatible medical devices and accessories, disposables and services. Its MRidium 3870 MRI Compatible IV infusion pump system provides a non-magnetic Intravenous (IV) infusion pump system that is specifically designed for safe use during MRI procedures. Its MRidium 3860+ MRI Compatible IV infusion pump system has been designed with a non-magnetic ultrasonic motor with non-ferrous parts and other special features to safely and predictably and other IV fluids during various MRI procedures. Its IRadimed 3880 MRI Compatible patient vital signs monitoring system has been designed with non-magnetic components and other features to safely and accurately during various MRI procedures. The Company sells its products primarily to hospitals and acute care facilities. The IRADIMED 3880 system operates dependably on magnetic fields of over 30,000 gauss.
Employees
166
Date Price Change Volume
08/07/26 US$96.64 -3.60% 182,326
07/07/26 US$100.24 -2.01% 113,717
06/07/26 US$102.30 +1.32% 110,886
02/07/26 US$100.97 +2.99% 130,062
01/07/26 US$98.04 +2.60% 154,909
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
100.24USD
Average target price
118.00USD
Spread / Average Target
+17.72%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRMD Stock